BeOne Medicines registers Phase 1 bioavailability study for PRMT5 inhibitor BGB-58067Jul 17Weekly roundup, 2 itemsalcestobartBeiGene
BeiGene's LBL-007/tislelizumab colorectal cancer trial posts resultsJun 30Trial updatealcestobartBeiGene
Sign inSign in